The purpose of this guidance is to identify the types of decision support software functionalities that: (1) do not meet the definition of a device as amended by the Cures Act; (2) may meet the definition of a device but for which FDA does not intend to enforce compliance with applicable requirements of the FD&C Act, including, but not limited to, premarket clearance and premarket approval requirements; and (3) FDA intends to focus its regulatory oversight on.
News & Trends
Procurar
Recentes
- Commission presents a new project that looks at combined studies. COMBINE CTR-IVDR-MDR . ANALYSIS PHASE REPORT
- OECD – OCDE issued a report on artificial intelligence in health
- FDA Guidance Remanufacturing of Medical Devices
- Formação BPD de MEDICAMENTOS : Formação muito completa , com vários exemplos de casos práticos “
- MASTER COURSE SUPLEMENTOS ALIMENTARES : “Excelente formação com muito conhecimento técnico e aplicabilidade no dia-a-dia.”
- MSSG – Recomendações para robustecer as cadeias de abastecimento de medicamentos críticos
- Impact of AI on the regulation of medical products. Implementing the AI White Paper principles
- Essential Principles of Safety and Performance of Medical Devices and IVD Medical Devices